Theravance Biopharma (TBPH) Retained Earnings (2014 - 2026)
Theravance Biopharma (TBPH) posted Retained Earnings of -$870.46 million for Q2 2026, compared with -$924.27 million a year earlier.
Powered by 
Analysis
Theravance Biopharma (TBPH) Retained Earnings (2014 - 2026) Analysis & Trends
At the end of FY2025, Theravance Biopharma's Retained Earnings came in at -$859.63 million.
- In prior years, Theravance Biopharma's Retained Earnings was -$965.52 million in FY2024, -$909.1 million in FY2023, -$853.91 million in FY2022 and -$1.73 billion in FY2021.
- Quarterly Retained Earnings has run from a low of -$1.76 billion in Q2 2022 to a high of -$843.55 million in Q3 2022 over five years.
- According to Business Quant data, Retained Earnings for the three prior quarters was -$864.56 million (Q1 2026), -$859.63 million (Q4 2025) and -$920.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 31.89 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 171.67 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | -17.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 63.27 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 12.59 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | -22.28 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 2.20 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 112.09 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | -870.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -870.46 Mn |
| Mar 31, 2026 | -864.56 Mn |
| Dec 31, 2025 | -859.63 Mn |
| Sep 30, 2025 | -920.65 Mn |
| Jun 30, 2025 | -924.27 Mn |
| Mar 31, 2025 | -979.10 Mn |
| Dec 31, 2024 | -965.52 Mn |
| Sep 30, 2024 | -950.00 Mn |
| Jun 30, 2024 | -937.30 Mn |
| Mar 31, 2024 | -920.77 Mn |
| Dec 31, 2023 | -909.10 Mn |
| Sep 30, 2023 | -900.59 Mn |
| Jun 30, 2023 | -891.64 Mn |
| Mar 31, 2023 | -876.00 Mn |
| Dec 31, 2022 | -853.91 Mn |
| Sep 30, 2022 | -843.55 Mn |
| Jun 30, 2022 | -1.76 Bn |
| Mar 31, 2022 | -1.75 Bn |
| Dec 31, 2021 | -1.73 Bn |
| Sep 30, 2021 | -1.69 Bn |
API Access
Theravance Biopharma Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();